Related Experiment Video
Updated: Jul 6, 2026
06:35
In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Equine atypical myopathy: a review
Dominique-M Votion1, Didier Serteyn
1Equine Teaching Hospital, Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium. dominique.votion@ulg.ac.be
Veterinary Journal (London, England : 1997)
|April 1, 2008
Summary
Atypical myopathy (AM) in horses is a serious muscle-wasting disease. This review analyzes outbreaks to better understand its epidemiology and guide management strategies for affected equines.
Area of Science:
- Veterinary Medicine
- Equine Health
- Pathology
Background:
- Atypical myopathy (AM) is an acute rhabdomyolysis syndrome affecting grazing equines.
- Recent years have seen an increase in reported AM outbreaks globally, including in previously unaffected regions.
Purpose of the Study:
- To analyze clinical and epidemiological data of AM outbreaks.
- To better define the epidemiological profile of atypical myopathy.
- To discuss potential etiologies and characterize the physiopathology of AM.
Main Methods:
- Review of clinical and epidemiological details from AM outbreaks.
- Analysis of biochemical and pathological findings.
- Integration of histopathological data for physiopathological characterization.
Main Results:
- AM outbreaks present an increasing epidemiological concern.
- Clinical, biochemical, and pathological findings provide insights into AM's nature.
- Understanding the physiopathology aids in medical management.
Conclusions:
- Further epidemiological surveillance and recording of new AM cases are essential.
- Establishing an epidemiological network is recommended for ongoing monitoring.
- Informed medical management strategies can be developed based on integrated findings.
More Related Videos
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...